Correlation Between DexCom and Co Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DexCom and Co Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DexCom and Co Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DexCom Inc and Co Diagnostics, you can compare the effects of market volatilities on DexCom and Co Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DexCom with a short position of Co Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DexCom and Co Diagnostics.

Diversification Opportunities for DexCom and Co Diagnostics

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between DexCom and CODX is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding DexCom Inc and Co Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Co Diagnostics and DexCom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DexCom Inc are associated (or correlated) with Co Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Co Diagnostics has no effect on the direction of DexCom i.e., DexCom and Co Diagnostics go up and down completely randomly.

Pair Corralation between DexCom and Co Diagnostics

Given the investment horizon of 90 days DexCom Inc is expected to generate 0.38 times more return on investment than Co Diagnostics. However, DexCom Inc is 2.6 times less risky than Co Diagnostics. It trades about -0.07 of its potential returns per unit of risk. Co Diagnostics is currently generating about -0.12 per unit of risk. If you would invest  7,800  in DexCom Inc on December 28, 2024 and sell it today you would lose (853.00) from holding DexCom Inc or give up 10.94% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

DexCom Inc  vs.  Co Diagnostics

 Performance 
       Timeline  
DexCom Inc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days DexCom Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Co Diagnostics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Co Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

DexCom and Co Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DexCom and Co Diagnostics

The main advantage of trading using opposite DexCom and Co Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DexCom position performs unexpectedly, Co Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Co Diagnostics will offset losses from the drop in Co Diagnostics' long position.
The idea behind DexCom Inc and Co Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity